InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| CL097 | Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablat... | 2021 | Front Immunol. | Wright J.A. et al. | DOI: 10.3389/fimmu.2021.705307 |
| ODN 1826 - TLR9 ligand | Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablat... | 2021 | Front Immunol. | Wright J.A. et al. | DOI: 10.3389/fimmu.2021.705307 |
| Fungin™ - Antifungal Reagent | Bioreactor-Based De-epithelialization of Long-Segment Tracheal Grafts. | 2021 | Methods Mol Biol. | Marin-Araujo A.E. et al. | DOI: 10.1007/7651_2021_431 |
| LPS-EB (LPS from E. coli O111:B4) | Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prev... | 2021 | Cell Host Microbe | Luchetti G. et al. | DOI: 10.1016/j.chom.2021.08.010 |
| Primocin® | Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vi... | 2021 | J Transl Med. | Kryeziu K. et al. | DOI: 10.1186/s12967-021-03062-3 |
| FGF 2 | Investigation of the potential therapeutic effect of cationic lipoplex mediat... | 2021 | Daru. | Erel-Akbaba G. & Akbaba H. | DOI: 10.1007/s40199-021-00410-y |
| ODN 1826 VacciGrade™ | Engineered SARS-CoV-2 receptor binding domain improves manufacturability in y... | 2021 | PNAS | Dalvie N.C. et al. | DOI: 10.1073/pnas.2106845118 |
| Alhydrogel® adjuvant 2% | Engineered SARS-CoV-2 receptor binding domain improves manufacturability in y... | 2021 | PNAS | Dalvie N.C. et al. | DOI: 10.1073/pnas.2106845118 |
| Imiquimod (R837) | Innate immune responses after stimulation with Toll-like receptor agonists in... | 2021 | J Neuroinflammation | Carroll J.A. et al. | DOI: 10.1186/s12974-021-02240-w |
| ODN 1585 - TLR9 ligand | Innate immune responses after stimulation with Toll-like receptor agonists in... | 2021 | J Neuroinflammation | Carroll J.A. et al. | DOI: 10.1186/s12974-021-02240-w |
| Primocin® | Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 ... | 2021 | J Exp Clin Cancer Res. | Przygodzka P. et al. | DOI: 10.1186/s13046-021-02073-8 |
| PMA - Phorbol myristate acetate | Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 ... | 2021 | J Exp Clin Cancer Res. | Przygodzka P. et al. | DOI: 10.1186/s13046-021-02073-8 |
| PlasmoTest™ - Mycoplasma Detection Kit | Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 ... | 2021 | J Exp Clin Cancer Res. | Przygodzka P. et al. | DOI: 10.1186/s13046-021-02073-8 |
| ssPolyU Naked | A TLR7 antagonist restricts interferon-dependent and -independent immunopatho... | 2021 | J Exp Med. | Rappe J.C.F. et al. | DOI: 10.1084/jem.20201631 |
| ODN 2216 - TLR9 ligand | A TLR7 antagonist restricts interferon-dependent and -independent immunopatho... | 2021 | J Exp Med. | Rappe J.C.F. et al. | DOI: 10.1084/jem.20201631 |
| LyoVec™ | A TLR7 antagonist restricts interferon-dependent and -independent immunopatho... | 2021 | J Exp Med. | Rappe J.C.F. et al. | DOI: 10.1084/jem.20201631 |
| 2'3'-cGAMP | The Smac mimetic BV6 cooperates with STING to induce necroptosis in apoptosis... | 2021 | Cell Death Dis. | Hannes S. et al. | DOI: 10.1038/s41419-021-04014-x |
| THP1-Dual™ Cells | Inhibition of IRGM establishes a robust antiviral immune state to restrict pa... | 2021 | EMBO Rep. | Nath P. et al. | DOI: 10.15252/embr.202152948 |
| Poly(dA:dT) | Inhibition of IRGM establishes a robust antiviral immune state to restrict pa... | 2021 | EMBO Rep. | Nath P. et al. | DOI: 10.15252/embr.202152948 |
| QUANTI-Luc™: Luciferase Detection Reagent | Inhibition of IRGM establishes a robust antiviral immune state to restrict pa... | 2021 | EMBO Rep. | Nath P. et al. | DOI: 10.15252/embr.202152948 |